Oral Microbiome Products Market Report 2026

The oral microbiome products market size has grown rapidly in recent years. It will grow from $1.06 billion in 2025 to $1.21 billion in 2026 at a compound annual growth rate (CAGR) of 14.3%. The growth in the historic period can be attributed to increasing prevalence of dental caries and periodontal diseases, rising consumer awareness of oral hygiene, growth in probiotic research for gut and oral health, expansion of retail pharmacy distribution networks, increasing adoption of preventive dental care practices.

The oral microbiome products market size is expected to see rapid growth in the next few years. It will grow to $2.08 billion by 2030 at a compound annual growth rate (CAGR) of 14.5%. The growth in the forecast period can be attributed to rising demand for personalized microbiome based oral care solutions, increasing integration of ai in oral health diagnostics, growth in preventive healthcare and wellness trends, expansion of e-commerce distribution for oral care products, rising investment in biotechnology based oral therapeutics. Major trends in the forecast period include growing adoption of probiotic based oral care formulations targeting microbiome balance, increasing use of next generation sequencing for oral microbiome profiling, rising demand for personalized oral health supplements based on microbiome analysis, expansion of AI driven microbiome diagnostics for early detection of oral diseases, growing preference for functional oral care products such as probiotic toothpastes and rinses.

The increasing prevalence of dental diseases is expected to drive the growth of the oral microbiome products market going forward. Dental diseases refer to oral health conditions such as dental caries, gingivitis, and periodontal diseases, which are becoming more common due to factors including poor oral hygiene, high sugar intake, tobacco consumption, and limited access to preventive dental care. The prevalence of dental diseases is rising as global healthcare systems report higher incidence rates, while growing awareness contributes to improved diagnosis and reporting. Oral microbiome products assist in managing dental diseases by restoring microbial balance within the oral cavity, suppressing the growth of pathogenic bacteria associated with caries and periodontal conditions, and promoting beneficial oral flora to maintain oral health and prevent disease progression. For instance, in March 2025, according to the World Health Organization, a Switzerland-based global public health authority, oral diseases affected around 3.7 billion people worldwide, with untreated dental caries in permanent teeth recognized as the most common health condition globally. Therefore, the increasing prevalence of dental diseases is driving the growth of the oral microbiome products market.

The growing global aging population is anticipated to drive the expansion of the oral microbiome products market in the coming years. The aging population refers to the increasing share of older individuals within the worldwide population, mainly resulting from longer life expectancy and lower birth rates. Improvements in healthcare systems, enhanced living conditions, and more effective disease management have enabled people to live longer and maintain better overall health, contributing to this demographic shift. Oral microbiome products help support the aging population by maintaining a balanced oral microbial environment, limiting the growth of harmful bacteria linked to oral diseases, and improving oral health through preventive and restorative care solutions. According to the World Health Organization, the global population aged 60 years and above reached approximately 1.1 billion in 2023 and is projected to increase to around 1.4 billion by 2030. Consequently, the rising aging population worldwide is contributing to the growth of the oral microbiome products market.

Leading companies operating in the oral microbiome products market are focusing on developing innovative microbiome-based solutions, such as advanced oral health monitoring and probiotic formulations, to address the growing demand for preventive, natural, and personalized oral care. These advancements enable targeted modulation of the oral microbiota, providing a more precise and sustainable approach compared to conventional products that may disrupt overall microbial balance. For instance, in October 2024, Boka, a US-based oral care company, launched Boka Well Pre and Probiotic Supplements, an innovative microbiome-focused product line developed to support oral and overall health. This product line includes Vital Bite Pre + Probiotic Tablets and Pro Stix Pre + Probiotic Powder, formulated with ingredients such as Streptococcus salivarius K12, inulin, and essential vitamins to encourage beneficial bacterial growth and maintain oral microbial balance. The supplements are designed to improve breath freshness, support gum health, and strengthen immunity by targeting the oral microbiome as the gateway to systemic health. Unlike conventional oral care products that provide temporary relief, these formulations work at the microbial level to deliver long-term benefits. Additionally, the products are non-toxic, fluoride-free, and free from artificial additives, aligning with the growing demand for clean-label and science-backed oral care innovations.

Major companies operating in the oral microbiome products market are Cargill Incorporated, Archer-Daniels-Midland Company, Johnson & Johnson, Procter & Gamble (P&G), Unilever PLC, GlaxoSmithKline plc, 3M Company, Colgate-Palmolive Company, Kao Corporation, Kerry Group, Nestlé Health Science, Church & Dwight Co. Inc., Lion Corporation, Novozymes A/S, Sunstar, Biogaia AB, U. S. Oral Care Inc., Blis Technologies Limited, Lallemand Health Solutions, Hyperbiotics, GLG Life Tech, Oragenics Inc., Evora Biosciences.

North America was the largest region in the oral microbiome products market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oral microbiome products market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the oral microbiome products market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The oral microbiome products market consists of sales of probiotic oral care products, prebiotic formulations, toothpaste, mouthwash, oral sprays, lozenges, and chewing gums. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.